BACKGROUND AND OBJECTIVE: Current treatments of port-wine stain birthmarks typically involve use of a pulsed dye laser (PDL) combined with cooling of the skin. Currently, PDL therapy protocols result in varied success, as some patients experience complete blanching, while others do not. Over the past decade, we have studied the use of photodynamic therapy (PDT) as either a replacement or adjuvant treatment option to photocoagulate both small and large vasculature. The objective of the current study was to evaluate a PDT protocol that involves use of an alternate intravascular photosensitizer mono-L-aspartylchlorin-e6 (NPe6) activated by an array of low-cost light emitting diodes. STUDY DESIGN/ MATERIALS AND METHODS: To monitor the microvasculature, a dorsal window chamber model was installed on 22 adult male mice. The light source consisted of a custom-built LED array that emitted 10 W at a center wavelength of 664 nm (FWHM = 20 nm). The light source was positioned at a fixed distance from the window chamber to achieve a fixed irradiance of 127 mW/cm(2). A retroorbital injection of NPe6 (5 mg/kg) was performed to deliver the drug into the bloodstream. Laser irradiation was initiated immediately after injection. To monitor blood-flow dynamics in response to PDT, we used laser speckle imaging. We employed a dose-response experimental design to evaluate the efficacy of NPe6-mediated PDT. RESULTS: We observed three general hemodynamic responses to PDT: (1) At low radiant exposures, we did not observe any persistent vascular shutdown; (2) at intermediate radiant exposures, we observed an acute decrease in blood flow followed by gradual restoration of blood flow over the 7-day monitoring period; and (3) at high radiant exposures, we observed acute vascular shutdown that persisted during the entire 7-day monitoring period. Dose-response analysis enabled identification of 85 J/cm(2) as a characteristic radiant exposure required to achieve persistent vascular shutdown at Day 7 following PDT. CONCLUSION: The experimental data suggest that NPe6-mediated PDT can achieve persistent vascular shutdown of normal microvasculature.
BACKGROUND AND OBJECTIVE: Current treatments of port-wine stain birthmarks typically involve use of a pulsed dye laser (PDL) combined with cooling of the skin. Currently, PDL therapy protocols result in varied success, as some patients experience complete blanching, while others do not. Over the past decade, we have studied the use of photodynamic therapy (PDT) as either a replacement or adjuvant treatment option to photocoagulate both small and large vasculature. The objective of the current study was to evaluate a PDT protocol that involves use of an alternate intravascular photosensitizer mono-L-aspartylchlorin-e6 (NPe6) activated by an array of low-cost light emitting diodes. STUDY DESIGN/ MATERIALS AND METHODS: To monitor the microvasculature, a dorsal window chamber model was installed on 22 adult male mice. The light source consisted of a custom-built LED array that emitted 10 W at a center wavelength of 664 nm (FWHM = 20 nm). The light source was positioned at a fixed distance from the window chamber to achieve a fixed irradiance of 127 mW/cm(2). A retroorbital injection of NPe6 (5 mg/kg) was performed to deliver the drug into the bloodstream. Laser irradiation was initiated immediately after injection. To monitor blood-flow dynamics in response to PDT, we used laser speckle imaging. We employed a dose-response experimental design to evaluate the efficacy of NPe6-mediated PDT. RESULTS: We observed three general hemodynamic responses to PDT: (1) At low radiant exposures, we did not observe any persistent vascular shutdown; (2) at intermediate radiant exposures, we observed an acute decrease in blood flow followed by gradual restoration of blood flow over the 7-day monitoring period; and (3) at high radiant exposures, we observed acute vascular shutdown that persisted during the entire 7-day monitoring period. Dose-response analysis enabled identification of 85 J/cm(2) as a characteristic radiant exposure required to achieve persistent vascular shutdown at Day 7 following PDT. CONCLUSION: The experimental data suggest that NPe6-mediated PDT can achieve persistent vascular shutdown of normal microvasculature.
Authors: Tia K Smith; Bernard Choi; Julio C Ramirez-San-Juan; J Stuart Nelson; Kathryn Osann; Kristen M Kelly Journal: Lasers Surg Med Date: 2006-06 Impact factor: 4.025
Authors: K F Chan; D X Hammer; B Choi; J M Teichman; H S McGuff; H Pratisto; E D Jansen; A J Welch Journal: J Endourol Date: 2000-03 Impact factor: 2.942
Authors: Austin J Moy; Sean M White; Elmer S Indrawan; Justin Lotfi; Matthew J Nudelman; Samantha J Costantini; Nikita Agarwal; Wangcun Jia; Kristen M Kelly; Brian S Sorg; Bernard Choi Journal: Microvasc Res Date: 2011-07-23 Impact factor: 3.514
Authors: J C Ramirez-San-Juan; E Mendez-Aguilar; N Salazar-Hermenegildo; A Fuentes-Garcia; R Ramos-Garcia; B Choi Journal: Biomed Opt Express Date: 2013-08-30 Impact factor: 3.732
Authors: Christian Crouzet; John Quan Nguyen; Adrien Ponticorvo; Nicole P Bernal; Anthony J Durkin; Bernard Choi Journal: Burns Date: 2015-03-24 Impact factor: 2.744
Authors: Ben Lertsakdadet; Bruce Y Yang; Cody E Dunn; Adrien Ponticorvo; Christian Crouzet; Nicole Bernal; Anthony J Durkin; Bernard Choi Journal: J Biomed Opt Date: 2018-03 Impact factor: 3.170
Authors: Wesley J Moy; Jonathan Yao; Sébastien M de Feraudy; Sean M White; Jocelynda Salvador; Kristen M Kelly; Bernard Choi Journal: Lasers Surg Med Date: 2017-05-10 Impact factor: 4.025
Authors: Bernard Choi; Wenbin Tan; Wangcun Jia; Sean M White; Wesley J Moy; Bruce Y Yang; Jiang Zhu; Zhongping Chen; Kristen M Kelly; J Stuart Nelson Journal: IEEE J Sel Top Quantum Electron Date: 2015-10-26 Impact factor: 4.544
Authors: Wesley J Moy; Joshua D Yakel; O Cecilia Osorio; Jocelynda Salvador; Carole Hayakawa; Kristen M Kelly; Bernard Choi Journal: Lasers Surg Med Date: 2015-07-31 Impact factor: 4.025